US Stock MarketDetailed Quotes
GEHC GE HealthCare Technologies
- 87.460
- +0.270+0.31%
Close Sep 12 16:00 ET
- 86.390
- -1.070-1.22%
Post 20:01 ET
39.94BMarket Cap25.35P/E (TTM)
87.470High86.040Low1.39MVolume87.020Open87.190Pre Close121.40MTurnover0.33%Turnover Ratio28.86P/E (Static)456.66MShares94.43052wk High5.12P/B37.18BFloat Cap62.27952wk Low0.12Dividend TTM425.10MShs Float94.430Historical High0.14%Div YieldTTM1.64%Amplitude52.875Historical Low87.065Avg Price1Lot Size
GE HealthCare Technologies Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -77.61%-119M | -10.47%419M | -1.55%2.1B | -1.22%1.05B | 4.50%650M | -252.63%-67M | 0.00%468M | 32.79%2.13B | 9,763.64%1.06B | 622M |
| Net income from continuing operations | 0.46%435M | 1.31%388M | -16.98%1.62B | -26.63%416M | -21.86%386M | -10.91%433M | -4.73%383M | -14.33%1.95B | -1.56%567M | --494M |
| Operating gains losses | 11.28%-173M | 7.81%-177M | -7,555.56%-689M | ---139M | -5,333.33%-163M | -6,400.00%-195M | -6,300.00%-192M | -280.00%-9M | --0 | ---3M |
| Depreciation and amortization | -4.49%149M | -5.73%148M | -3.63%610M | -8.28%144M | -4.38%153M | -0.64%156M | -1.26%157M | 1.28%633M | 1.95%157M | --160M |
| Deferred tax | 4.38%143M | -23.93%124M | 31.97%743M | 27.81%193M | 95.31%250M | -10.46%137M | 24.43%163M | -6.17%563M | -15.64%151M | --128M |
| Other non cash items | 105.00%3M | -232.00%-166M | 715.79%310M | -59.95%346M | 112.67%74M | 72.09%-60M | -85.19%-50M | 245.45%38M | 71.77%864M | ---584M |
| Change In working capital | -28.72%-511M | 81.18%154M | 48.83%-131M | 28.31%213M | 8.57%-32M | -5.31%-397M | 950.00%85M | 81.31%-256M | 118.67%166M | ---35M |
| -Change in receivables | 29.63%-57M | 4,100.00%200M | 61.14%-171M | 87.70%-23M | -1,340.00%-62M | -1.25%-81M | 97.19%-5M | 61.94%-440M | 69.94%-187M | --5M |
| -Change in inventory | -14.00%-57M | 51.64%-59M | 127.61%111M | 40.00%196M | 191.58%87M | 75.37%-50M | 50.00%-122M | 7.59%-402M | 225.00%140M | ---95M |
| -Change in payables and accrued expense | 10.42%-129M | -66.67%31M | -121.65%-97M | -33.06%83M | -243.33%-129M | -42.57%-144M | -72.24%93M | 85.12%448M | 215.89%124M | --90M |
| -Change in other working capital | -119.67%-268M | -115.13%-18M | -81.16%26M | -148.31%-43M | 305.71%72M | -1,842.86%-122M | 54.55%119M | 757.14%138M | 285.42%89M | ---35M |
| Cash from discontinued investing activities | 0 | -21M | ||||||||
| Operating cash flow | -77.61%-119M | -10.47%419M | -0.57%2.1B | 0.77%1.05B | 4.50%650M | -252.63%-67M | 0.00%468M | 31.49%2.11B | 9,572.73%1.04B | --622M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -315.48%-349M | 29.32%-188M | -40.20%-558M | 7.37%-88M | -1.69%-120M | 1.18%-84M | -166.00%-266M | 77.40%-398M | 93.80%-95M | -118M |
| Net PPE purchase and sale | 7.25%-64M | -1.40%-145M | -26.14%-386M | -23.68%-94M | -8.11%-80M | -16.95%-69M | -47.42%-143M | -31.33%-306M | 3.80%-76M | ---74M |
| Net business purchase and sale | -1,195.00%-259M | --0 | ---147M | --0 | --0 | ---20M | ---127M | --0 | --0 | --0 |
| Net other investing changes | -620.00%-26M | -1,175.00%-43M | 72.83%-25M | 131.58%6M | 9.09%-40M | 119.23%5M | 233.33%4M | -95.74%-92M | -533.33%-19M | ---44M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -315.48%-349M | 29.32%-188M | -40.20%-558M | 7.37%-88M | -1.69%-120M | 1.18%-84M | -166.00%-266M | 77.40%-398M | 93.80%-95M | ---118M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 74.89%-57M | -122.73%-153M | 41.85%-478M | -2,332.43%-900M | 95.25%-24M | -262.14%-227M | 260.24%673M | -212.55%-822M | -102.64%-37M | -505M |
| Net issuance payments of debt | -33.33%-4M | -107.61%-151M | -86.12%1.14B | -110.53%-863M | 150.00%20M | -50.00%-3M | 198,400.00%1.99B | 68,466.67%8.2B | 273,333.33%8.2B | --8M |
| Cash dividends paid | 0.00%-14M | ---14M | ---41M | ---13M | ---14M | ---14M | --0 | --0 | --0 | --0 |
| Net other financing activities | 81.43%-39M | 100.91%12M | 82.54%-1.58B | 99.71%-24M | 94.15%-30M | -247.89%-210M | -211.64%-1.31B | -3,496.02%-9.03B | -686.47%-8.23B | ---513M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 74.89%-57M | -122.73%-153M | 41.85%-478M | -2,332.43%-900M | 95.25%-24M | -262.14%-227M | 260.24%673M | -212.55%-822M | -102.64%-37M | ---505M |
| Net cash flow | ||||||||||
| Beginning cash position | 9.90%2.57B | 72.71%2.51B | 158.65%1.45B | 380.16%2.42B | 266.98%1.95B | 361.26%2.33B | 158.65%1.45B | -44.57%561M | -29.41%504M | --530M |
| Current changes in cash | -38.89%-525M | -91.09%78M | 19.26%1.07B | -93.19%62M | 50,700.00%506M | -1,150.00%-378M | 1,782.69%875M | 314.15%893M | 740.85%910M | ---1M |
| Effect of exchange rate changes | -100.00%-22M | -337.50%-19M | -233.33%-10M | -35.14%24M | -24.00%-31M | 8.33%-11M | 366.67%8M | 91.18%-3M | 436.36%37M | ---25M |
| End cash Position | 3.75%2.02B | 9.90%2.57B | 72.71%2.51B | 72.71%2.51B | 380.16%2.42B | 266.98%1.95B | 361.26%2.33B | 158.65%1.45B | 158.65%1.45B | --504M |
| Free cash flow | -33.58%-183M | -15.69%274M | -4.94%1.71B | -0.93%956M | 4.01%570M | -75.64%-137M | -11.68%325M | 32.67%1.8B | 1,248.81%965M | --548M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg